Purple Biotech Stock Price Target
Data is currently not available. Earnings for purple biotech are expected to decrease in the coming year, from ($0.40) to ($0.50) per share.
Hc wainwright subscribe to marketbeat all access for the recommendation accuracy rating:
Purple biotech stock price target. 10, 2021 at 12:07 p.m. Implicit in this philosophy is the importance of sound corporate governance. Price to earnings ratio vs.
Adr stock information by barron's. Learn more on ppbt's analyst rating history According to 1 wall street analysts that have issued a 1 year ppbt price target, the average ppbt price target is $25.00, with the highest ppbt stock price forecast at $25.00 and the lowest ppbt stock price forecast at $25.00.
How much money does purple biotech make? Wall street stock market & finance report, prediction for the future: American depositary shares (ppbt) nasdaq listed.
What is purple biotech's stock price today? Find the latest purple biotech ltd. According to the issued ratings of 1 analysts in the last year, the consensus rating for purple biotech stock is buy based on the current 1 buy rating for ppbt.
It operates through two segments: Wainwright reiterates their buy rating on purple biotech (ppbt) This price target is based on 12 analysts offering 12 month price targets for purple innovation in the last 3 months.
The stock opened with a gain of 5.03% at $3.97 and touched an intraday high of $3.9900, rising 5.56% against the last close of $3.78. Is a development stage pharmaceutical company, which engages in drug development. This price target is based on 1 analysts offering 12 month price targets for purple biotech in the last 3 months.
One share of ppbt stock can currently be purchased for approximately $3.74. Ppbt purple biotech adr — stock price and discussion | stocktwits. The average price target is $25.00, with a high forecast of $25.00 and a low forecast of $25.00.
According to the issued ratings of 12 analysts in the last year, the consensus rating for purple innovation stock is hold based on the current 2 sell ratings, 6 hold ratings and 4 buy ratings for prpl. 9 things for investors to know about purple biotech as shares surge feb. It is the duty of the board of directors to serve as a prudent fiduciary for shareholders and to oversee the management of the company’s business.
Purple biotech ltd.’s board of directors sets high standards for the company’s employees, officers and directors. The oncology segment includes nt219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer. Purple biotech adr nasdaq updated dec 6, 2021 9:30 pm.
The average price target is $21.27, with a high forecast of $45.00 and a low forecast of $12.00. What is ppbt's price target? Oncology, and pain & hypertension.
(ppbt) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock went to a low of $3.9300 during the session. Price target upside/downside on report date details;
Komentar
Posting Komentar